During the past decade, Synexus Merseyside Clinical Research Centre conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 15 clinical trials were completed, i.e. on average, 115.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Merseyside Clinical Research Centre" #1 sponsor was "Kowa Research Europe" with 6 trials, followed by "Pfizer" with 5 trials sponsored, "Phathom Pharmaceuticals, Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Merseyside Clinical Research Centre" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Merseyside Clinical Research Centre" are "Dyslipidemia" (5 trials), "Cardiovascular Disease" (2 trials), "Hypercholesterolemia" (2 trials), "Hyperlipidemia" (2 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Synexus Merseyside Clinical Research Centre" in a lesser frequency.

Most popular intervention types in "Synexus Merseyside Clinical Research Centre" are "Drug" (23 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Pitavastatin" (6 trials), "Atorvastatin" (3 trials), "Bococizumab (PF-04950615; RN316)" (2 trials) and "Lansoprazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Merseyside Clinical Research Centre" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Synexus Merseyside Clinical Research Centre". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Synexus Merseyside Clinical Research Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Merseyside Clinical Research Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".